Literature DB >> 29768164

Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells.

Bertram Bengsch1, Takuya Ohtani2, Omar Khan3, Manu Setty4, Sasikanth Manne5, Shaun O'Brien6, Pier Federico Gherardini7, Ramin Sedaghat Herati8, Alexander C Huang9, Kyong-Mi Chang10, Evan W Newell11, Niels Bovenschen12, Dana Pe'er4, Steven M Albelda6, E John Wherry13.   

Abstract

Exhausted CD8 T (Tex) cells are immunotherapy targets in chronic infection and cancer, but a comprehensive assessment of Tex cell diversity in human disease is lacking. Here, we developed a transcriptomic- and epigenetic-guided mass cytometry approach to define core exhaustion-specific genes and disease-induced changes in Tex cells in HIV and human cancer. Single-cell proteomic profiling identified 9 distinct Tex cell clusters using phenotypic, functional, transcription factor, and inhibitory receptor co-expression patterns. An exhaustion severity metric was developed and integrated with high-dimensional phenotypes to define Tex cell clusters that were present in healthy subjects, common across chronic infection and cancer or enriched in either disease, linked to disease severity, and changed with HIV therapy. Combinatorial patterns of immunotherapy targets on different Tex cell clusters were also defined. This approach and associated datasets present a resource for investigating human Tex cell biology, with implications for immune monitoring and immunomodulation in chronic infections, autoimmunity, and cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8 T cell; CyTOF; HIV; T cell exhaustion; cancer immunology; chronic infection; immune checkpoint; lung cancer; mass cytometry; systems immunology

Mesh:

Substances:

Year:  2018        PMID: 29768164      PMCID: PMC6010198          DOI: 10.1016/j.immuni.2018.04.026

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  35 in total

1.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

2.  Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection.

Authors:  Jill M Angelosanto; Shawn D Blackburn; Alison Crawford; E John Wherry
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 3.  Tissue-resident memory T cells.

Authors:  Jason M Schenkel; David Masopust
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

Authors:  Alexander C Huang; Michael A Postow; Robert J Orlowski; Rosemarie Mick; Bertram Bengsch; Sasikanth Manne; Wei Xu; Shannon Harmon; Josephine R Giles; Brandon Wenz; Matthew Adamow; Deborah Kuk; Katherine S Panageas; Cristina Carrera; Phillip Wong; Felix Quagliarello; Bradley Wubbenhorst; Kurt D'Andrea; Kristen E Pauken; Ramin S Herati; Ryan P Staupe; Jason M Schenkel; Suzanne McGettigan; Shawn Kothari; Sangeeth M George; Robert H Vonderheide; Ravi K Amaravadi; Giorgos C Karakousis; Lynn M Schuchter; Xiaowei Xu; Katherine L Nathanson; Jedd D Wolchok; Tara C Gangadhar; E John Wherry
Journal:  Nature       Date:  2017-04-10       Impact factor: 49.962

Review 6.  Targeting T Cell Co-receptors for Cancer Therapy.

Authors:  Margaret K Callahan; Michael A Postow; Jedd D Wolchok
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Ablation of CD8 and CD4 T cell responses by high viral loads.

Authors:  Michael J Fuller; Allan J Zajac
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

8.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

9.  Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.

Authors:  Michael A Paley; Daniela C Kroy; Pamela M Odorizzi; Jonathan B Johnnidis; Douglas V Dolfi; Burton E Barnett; Elizabeth K Bikoff; Elizabeth J Robertson; Georg M Lauer; Steven L Reiner; E John Wherry
Journal:  Science       Date:  2012-11-30       Impact factor: 47.728

10.  CD39 Expression Identifies Terminally Exhausted CD8+ T Cells.

Authors:  Prakash K Gupta; Jernej Godec; David Wolski; Emily Adland; Kathleen Yates; Kristen E Pauken; Cormac Cosgrove; Carola Ledderose; Wolfgang G Junger; Simon C Robson; E John Wherry; Galit Alter; Philip J R Goulder; Paul Klenerman; Arlene H Sharpe; Georg M Lauer; W Nicholas Haining
Journal:  PLoS Pathog       Date:  2015-10-20       Impact factor: 6.823

View more
  106 in total

Review 1.  Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.

Authors:  Kevin Hendrawan; Malini Visweswaran; David D F Ma; John J Moore
Journal:  Bone Marrow Transplant       Date:  2019-10-16       Impact factor: 5.483

Review 2.  Personal tumor antigens in blood malignancies: genomics-directed identification and targeting.

Authors:  Livius Penter; Catherine J Wu
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

3.  Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.

Authors:  Lola Jacquemont; Gaëlle Tilly; Michelle Yap; Tra-My Doan-Ngoc; Richard Danger; Pierrick Guérif; Florent Delbos; Bernard Martinet; Magali Giral; Yohann Foucher; Sophie Brouard; Nicolas Degauque
Journal:  J Am Soc Nephrol       Date:  2020-03-12       Impact factor: 10.121

4.  Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States.

Authors:  Spencer C Wei; Roshan Sharma; Nana-Ama A S Anang; Jacob H Levine; Yang Zhao; James J Mancuso; Manu Setty; Padmanee Sharma; Jing Wang; Dana Pe'er; James P Allison
Journal:  Immunity       Date:  2019-03-26       Impact factor: 31.745

5.  Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage.

Authors:  Carole Le Coz; Bertram Bengsch; Caroline Khanna; Melissa Trofa; Takuya Ohtani; Brian E Nolan; Sarah E Henrickson; Michele P Lambert; Taylor Olmsted Kim; Jenny M Despotovic; Scott Feldman; Olajumoke O Fadugba; Patricia Takach; Melanie Ruffner; Soma Jyonouchi; Jennifer Heimall; Kathleen E Sullivan; E John Wherry; Neil Romberg
Journal:  J Allergy Clin Immunol       Date:  2019-08-22       Impact factor: 10.793

6.  Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.

Authors:  Nathan Singh; Yong Gu Lee; Saar Gill; Marco Ruella; Olga Shestova; Pranali Ravikumar; Katharina E Hayer; Seok Jae Hong; Xueqing Maggie Lu; Raymone Pajarillo; Sangya Agarwal; Shunichiro Kuramitsu; Elena J Orlando; Karen Thudium Mueller; Charly R Good; Shelley L Berger; Ophir Shalem; Matthew D Weitzman; Noelle V Frey; Shannon L Maude; Stephan A Grupp; Carl H June
Journal:  Cancer Discov       Date:  2020-01-30       Impact factor: 39.397

Review 7.  Defining 'T cell exhaustion'.

Authors:  Christian U Blank; W Nicholas Haining; Werner Held; Patrick G Hogan; Axel Kallies; Enrico Lugli; Rachel C Lynn; Mary Philip; Anjana Rao; Nicholas P Restifo; Andrea Schietinger; Ton N Schumacher; Pamela L Schwartzberg; Arlene H Sharpe; Daniel E Speiser; E John Wherry; Benjamin A Youngblood; Dietmar Zehn
Journal:  Nat Rev Immunol       Date:  2019-09-30       Impact factor: 53.106

8.  TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.

Authors:  Zeyu Chen; Zhicheng Ji; Shin Foong Ngiow; Sasikanth Manne; Zhangying Cai; Alexander C Huang; John Johnson; Ryan P Staupe; Bertram Bengsch; Caiyue Xu; Sixiang Yu; Makoto Kurachi; Ramin S Herati; Laura A Vella; Amy E Baxter; Jennifer E Wu; Omar Khan; Jean-Christophe Beltra; Josephine R Giles; Erietta Stelekati; Laura M McLane; Chi Wai Lau; Xiaolu Yang; Shelley L Berger; Golnaz Vahedi; Hongkai Ji; E John Wherry
Journal:  Immunity       Date:  2019-10-09       Impact factor: 31.745

Review 9.  A systems approach to infectious disease.

Authors:  Manon Eckhardt; Judd F Hultquist; Robyn M Kaake; Ruth Hüttenhain; Nevan J Krogan
Journal:  Nat Rev Genet       Date:  2020-02-14       Impact factor: 53.242

10.  Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Authors:  Claire Gorby; Junel Sotolongo Bellón; Stephan Wilmes; Walid Warda; Elizabeth Pohler; Paul K Fyfe; Adeline Cozzani; Christophe Ferrand; Mark R Walter; Suman Mitra; Jacob Piehler; Ignacio Moraga
Journal:  Sci Signal       Date:  2020-09-15       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.